文献速递神经肿瘤

验证用于恶性胶质瘤手术中可视化5-ALA诱导PpIX荧光的新一代滤光系统的原理验证研究

Validating a new generation filter system for visualizing 5-ALA-induced PpIX fluorescence in malignant glioma surgery: a proof of principle study.
PubMed 文献 · Acta Neurochir (Wien) · 2020-02-07

本研究在32例恶性胶质瘤患者中比较新型BLUE 400 AR滤光系统与金标准BLUE 400对5-ALA诱导PpIX荧光的判别效果。BLUE 400 AR明显增强手术野亮度、改善脑解剖辨识,荧光边缘判别与阳性预测值(98.44%,95%CI 90.06-99.77%)与BLUE 400相当。作者认为BLUE 400 AR可被视为安全有效支持恶性胶质瘤手术。

要点

  • BLUE 400 AR较BLUE 400明显增强手术野亮度,脑解剖判别更优。
  • 荧光边缘阳性预测值为98.44%(95%CI 90.06-99.77%)。
  • 非荧光组织残留中位细胞密度为13%(IQR 13至31)。

核心结论

  • BLUE 400 AR在恶性胶质瘤手术中背景可视化优于传统BLUE 400,但荧光边缘判别与阳性预测值相当。
  • 作者认为BLUE 400 AR可被视为安全有效支持恶性胶质瘤手术。

研究设计与样本

  • 采用配备BLUE 400与BLUE 400 AR的手术显微镜,在生物学基础与视觉边缘感知上进行对比。
  • 由资深神经外科医生于术中及术后比较高分辨率图像。
  • 按预设活检算法,仅使用BLUE 400 AR从计划切除区域的PpIX荧光肿瘤边缘及相邻脑组织每例取4处活检,评估细胞计数与密度。
  • 共纳入32例恶性胶质瘤患者,采集荧光边缘活检128处。

主要发现

  • BLUE 400 AR明显增强手术野亮度,能更佳判别脑解剖。
  • 荧光边缘阳性预测值为98.44%(95%CI 90.06-99.77%)。
  • 非荧光组织残留中位细胞密度为13%(IQR 13至31)。
  • 在高清图像上,两种滤光组合对荧光边缘位置的感知相当。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The BLUE 400 filter system (Carl Zeiss Meditec, Oberkochen, Germany) has provided visualization of 5-ALA-induced fluorescence-guided surgery for more than 20 years. Nevertheless, constraints, e.g., limited background discrimination during hemostasis, obstruct fluency of surgery. A novel filter with improved background visualization was developed, requiring validation regarding fluorescence discrimination. The aim of this article is to determine diagnostic accuracy and perception of protoporphyrin IX (PpIX) discrimination of a novel filter system with higher background illumination (BLUE 400 AR) compared with the gold standard, BLUE 400. METHODS: A surgical microscope equipped with both BLUE 400 and BLUE 400 AR was used. Comparisons were performed on a biological basis and on the visual perception of margins. High-resolution images were compared during and after surgery by senior neurosurgeons. In a predefined biopsy algorithm, four biopsies per patient at tumor margins of PpIX fluorescence and adjacent brain were acquired using BLUE 400 AR only from regions intended for resection and assessed for cell count and density. RESULTS: Thirty-two patients with malignant gliomas were included in this study. BLUE 400 AR markedly enhanced the brightness of the surgical field, allowing superior discrimination of brain anatomy. A total of 128 biopsies from fluorescence margins were collected. Positive predictive value (PPV) was 98.44% (95% CI, 90.06-99.77%) for malignant glioma. Residual median cell density in non-fluorescent tissue was 13% (IQR 13 to 31). Perception of the location of fluorescent margins on HD images was equivalent for both filter combinations. CONCLUSIONS: BLUE 400 AR demonstrated superior background compared with conventional BLUE 400 in malignant glioma surgery but comparable fluorescence margins and PPV. Therefore, BLUE 400 AR can be considered safe and effective in supporting malignant glioma surgery.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Suero Molina E, Stögbauer L, Jeibmann A, et al. Validating a new generation filter system for visualizing 5-ALA-induced PpIX fluorescence in malignant glioma surgery: a proof of principle study. Acta Neurochir (Wien). 2020. PMID: 32034493. doi:10.1007/s00701-020-04227-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。